Eye movement desensitization and reprocessing (EMDR): efficacy in improving clinical, neuropsychological, and quality of life in women victims of violence
- Conditions
- Women exposed to gender-based violence who show symptoms of anxiety, depression and post-traumatic stress, in addition to low performance in cognitive functioning, or that limits performance in daily lifeMental and Behavioural Disorders
- Registration Number
- ISRCTN85117262
- Lead Sponsor
- Campus Grupal Foundation
- Brief Summary
2023 Other publications in https://doi.org/10.1089/whr.2023.0019 Clinical Neuropsychological Profile and Quality of Life in Women Who Have Suffered Gender-Based Violence (added 14/12/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 120
1. Exposed to gender violence (physical, psychological and/or sexual)
2. Between 18 and 50 years of age
3. Signed the informed consent form
1. Intelligence quotient (IQ) lower than 70
2. History of brain damage
3. History of severe neurological or psychiatric illness
4. History of toxic consumption
5. Presence of sensory alterations that impeded the performance of the tests
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment:<br>Neuropsychological functioning was measured using the following tests:<br>1. The Rey Auditory Verbal Learning Test RAV LT.<br>2. Coding - subtest WAIS IV.<br>3. Test D2. measures selective and sustained attention.<br>4. Trail Making Test, part A (TMT-A) and part B (TMT-B).<br>5. Stroop Test. An instrument that assesses complex attention.<br>6. Phonological Verbal Fluency Test PVFT.<br>7. Semantic Verbal Fluency Test SVFT. Assesses the ability to retrieve stored semantic information.<br>
- Secondary Outcome Measures
Name Time Method Measurements are made with the pretest (beginning of treatment, includes 10 sessions) and post-test (after 6 months) at the end of treatment:<br>1. Gender violence - Questionnaire on violence<br>2. Anxiety and depression are measured using the Hospital Anxiety and Depression Scale HADS scale<br>3. Posttraumatic Stress Disorder is measured using the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5)<br>4. Quality of Life is measured using GENCAT Scale